Search Results - david+irani

1 Results Sort By:
Diagnostic and Prognostic Markers and Treatment Strategies for Multiple Sclerosis
C04371: Novel Diagnostic and Prognostic Multiple Sclerosis Protein BiomarkerNovelty: A novel diagnostic and prognostic protein biomarker in Cerebral Spinal Fluid that is 100% specific for Multiple Sclerosis when compared to other neurologic disorders.Value Proposition: Current Multiple Sclerosis diagnosis is produced and confirmed strictly by clinical...
Published: 7/4/2024   |   Inventor(s): Caroline Anderson, David Irani, Robert Cotter, Norman Haughey, Joseph Steiner, Avindra Nath
Keywords(s): Biomarker, Chronic Inflammatory Diseases, Clinical Diagnostics, CNS and Neurological Disorders, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Multiple Sclerosis, Multiple Sclerosis (MS), Neurodegeneration, Prognostic Biomarker
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Autoimmunity, Clinical and Disease Specializations > Inflammation > Chronic Inflammatory Diseases, Clinical and Disease Specializations > Neurology > Multiple Sclerosis, Clinical and Disease Specializations > Neurology > Neurodegeneration, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Prognostics Biomarkers, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Inflammation, Clinical and Disease Specializations > Neurology, Clinical and Disease Specializations > Immunology
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum